TendoNova

Private

Atlanta, GeorgiaHealthcare & Life Scienceshttps://tendonova.com/

Last Round

Debt

Jun 26, 2024

Total Funding Raised

$2.47M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

TendoNova is a medical device company that develops and commercializes micro-invasive tools for orthopedic procedures, such as the FDA-cleared Ocelot system for treating chronic tendon pain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

minimally invasive surgerytendinopathy treatmentorthopedic medical deviceultrasonic tenotomysports medicineminimally invasivetenotomyambulatory surgery centerASCrazor and bladesorthopedic surgerymedical device manufacturerchronic tendon painsurgical instrument

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TendoNova Comps

Public and private peers based on sector, stage, and business model.

TendoNova comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TendoNova Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Jun 26, 2024
VC Round	Apr 12, 2024
Grant	Aug 5, 2021
Debt	Feb 2, 2021
Seed	Jun 11, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Brett Rogers

Chief Operating Officer

Executive Team

TendoNova Investors

Notable investors and investment history

TendoNova investors
Investor	Rounds
Georgia Research Alliance	Grant
Georgia Research Alliance	Seed, Grant
NFL Players Association	Seed
VentureSouth	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 24, 2026
Medical device has received FDA clearance.
Apr 12, 2024
$2M round led by VentureSouth

View all signals

TendoNova Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

TendoNova Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TendoNova's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia

Employee Range17

Year Founded2017

Last FundingJun 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.